Human Phenotype Ontology 
Grandparent Node:
expand
Neoplasm (HP:0002664)help
Parent Node:
expand
Abnormality of the skin (HP:0000951)help
Parent Node:
expand
Neoplasm by anatomical site (HP:0011793)help
..Starting node
..expand
Neoplasm of the skin (HP:0008069)help
Term ID: 8069
Name: Neoplasm of the skin
Synonym: Dermatological tumors; Dermatological tumours; Neoplasia of the skin; Skin cancer; Skin cancer (non-melanoma); Skin tumors; Skin tumours; Tumor of the skin; Tumour of the skin
Definition: A tumor (abnormal growth of tissue) of the skin.
Comments:
Reference: HP:0008069
Genes and Diseases:
 
       Child Nodes:
........expandSubcutaneous lipoma (HP:0001031) help
................... HP:0007596 Painful subcutaneous lipomas
........expandNeurofibromas (HP:0001067) help
................... HP:0005220 Multiple intestinal neurofibromatosis
................... HP:0006751 Paraspinal neurofibromas
................... HP:0007524 Atypical neurofibromatosis
................... HP:0007576 Palmar neurofibromas
................... HP:0009595 Occasional neurofibromas
................... HP:0009732 Plexiform neurofibroma
................... HP:0009735 Spinal neurofibromas
................... HP:0100698 Subcutaneous neurofibromas
........expandBasal cell carcinoma (HP:0002671) help
................... HP:0040098 Basalioma of the outer ear
........expandSquamous cell carcinoma (HP:0002860) help
................... HP:0006739 Squamous cell carcinoma of the skin
................... HP:0012182 Oropharyngeal squamous cell carcinoma
........expandCutaneous leiomyosarcoma (HP:0006755) help
........expandMyxoid subcutaneous tumors (HP:0006769) help
........expandCutaneous angiolipomas (HP:0006773) help
........expandMultiple cutaneous leiomyomas (HP:0007437) help
........expandFrontal cutaneous lipoma (HP:0007541) help
........expandMultiple cutaneous malignancies (HP:0007606) help
........expandCutaneous leiomyoma (HP:0007620) help
........expandPeripheral Schwannoma (HP:0009593) help
........expandAdenoma sebaceum (HP:0009720) help
........expandSteatocystoma multiplex (HP:0012035) help
........expandCutaneous melanoma (HP:0012056) help
................... HP:0012057 Superficial spreading melanoma
................... HP:0012058 Nodular melanoma
................... HP:0012059 Lentigo maligna melanoma
................... HP:0012060 Acral lentiginous melanoma
........expandPapilloma (HP:0012740) help
................... HP:0031021 Squamous Papilloma
................... HP:0040167 Facial papilloma
................... HP:0200022 Choroid plexus papilloma
................... HP:0200043 Verrucae
........expandSkin appendage neoplasm (HP:0012842) help
................... HP:0012843 Hair follicle neoplasm
................... HP:0030410 Sebaceous gland carcinoma
................... HP:0030434 Pilomatrixoma
................... HP:0031024 Cylindroma
................... HP:0031405 Poroma
................... HP:0031454 Apocrine hidrocystoma
................... HP:0031548 Follicular infundibulum tumor
........expandActinic keratosis (HP:0025127) help
........expandAcanthoma (HP:0025432) help
........expandCutaneous myxoma (HP:0030428) help
........expandFibrofolliculoma (HP:0030436) help
........expandMerkel cell skin cancer (HP:0030447) help
........expandEccrine syringofibroadenoma (HP:0031018) help
........expandSeborrheic keratosis (HP:0031287) help
........expandKeratoacanthoma (HP:0031525) help
........expandLymphocytoma cutis (HP:0031549) help
........expandKaposi's sarcoma (HP:0100726) help
........expandCutaneous mastocytosis (HP:0200151) help

 Sister Nodes: 
..expandHematological neoplasm (HP:0004377) help
..expandMalignant mesothelioma (HP:0100001) help
..expandNeoplasm of fatty tissue (HP:0200013) help
..expandNeoplasm of head and neck (HP:0012288) help
..expandNeoplasm of striated muscle (HP:0009728) help
..expandNeoplasm of the breast (HP:0100013) help
..expandNeoplasm of the ear (HP:0012780) help
..expandNeoplasm of the endocrine system (HP:0100568) help
..expandNeoplasm of the eye (HP:0100012) help
..expandNeoplasm of the gastrointestinal tract (HP:0007378) help
..expandNeoplasm of the genitourinary tract (HP:0007379) help
..expandNeoplasm of the heart (HP:0100544) help
..expandNeoplasm of the lip (HP:0100604) help
..expandNeoplasm of the nail (HP:0100826) help
..expandNeoplasm of the nervous system (HP:0004375) help
..expandNeoplasm of the oral cavity (HP:0100649) help
..expandNeoplasm of the pancreas (HP:0002894) help
..expandNeoplasm of the respiratory system (HP:0100606) help
..expandNeoplasm of the skeletal system (HP:0010622) help
..expandNeoplasm of the thymus (HP:0100521) help
..expandRetroperitoneal chemodectomas (HP:0006729) help
..expandSoft tissue neoplasm (HP:0031459) help
..expandVascular neoplasm (HP:0100742) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0008069HP:0008069Neoplasm of the skin0CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0008069Neoplasm of the skin0CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0008069Neoplasm of the skin0CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0008069Neoplasm of the skin0CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0008069Neoplasm of the skin0CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0008069Neoplasm of the skin0CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0008069Neoplasm of the skin0CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0008069Neoplasm of the skin0CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0008069Neoplasm of the skin0COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0008069Neoplasm of the skin0COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0008069Neoplasm of the skin0CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0008069Neoplasm of the skin0CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0008069Neoplasm of the skin0CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0008069Neoplasm of the skin0CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0008069Neoplasm of the skin0CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0008069Neoplasm of the skin0CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0008069Neoplasm of the skin0CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0008069Neoplasm of the skin0CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0008069Neoplasm of the skin0LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0008069Neoplasm of the skin0LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0008069Neoplasm of the skin0MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0008069Neoplasm of the skin0MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0008069Neoplasm of the skin0MUTYH CL E G H4595132600Pilomatrixoma132600C0206711OMIM119097527604933
HP:0008069HP:0008069Neoplasm of the skin0MUTYH CL E G H4595132600Pilomatrixoma132600C0206711OMIM117567527604933
HP:0008069HP:0008069Neoplasm of the skin0NOTCH3 CL E G H48542591Hamano Tsukamoto syndromeORPHA18607883600276
HP:0008069HP:0008069Neoplasm of the skin0NOTCH3 CL E G H48542591Hamano Tsukamoto syndromeORPHA19467883600276
HP:0008069HP:0008069Neoplasm of the skin0NTHL1 CL E G H4913616415Familial adenomatous polyposis 3616415C4225157OMIM17558028602656
HP:0008069HP:0008069Neoplasm of the skin0NTHL1 CL E G H4913616415Familial adenomatous polyposis 3616415C4225157OMIM19028028602656
HP:0008069HP:0008069Neoplasm of the skin0OCRL CL E G H4952534Acute myeloblastic leukemia without maturationORPHA14758108300535
HP:0008069HP:0008069Neoplasm of the skin0OCRL CL E G H4952534Acute myeloblastic leukemia without maturationORPHA14258108300535
HP:0008069HP:0008069Neoplasm of the skin0PDGFB CL E G H515531112ORPHA1938800190040
HP:0008069HP:0008069Neoplasm of the skin0PDGFB CL E G H515531112ORPHA1958800190040
HP:0008069HP:0008069Neoplasm of the skin0PDGFRB CL E G H51592591Hamano Tsukamoto syndromeORPHA13048804173410
HP:0008069HP:0008069Neoplasm of the skin0PDGFRB CL E G H51592591Hamano Tsukamoto syndromeORPHA12838804173410
HP:0008069HP:0008069Neoplasm of the skin0PMVK CL E G H10654175800Porokeratosis of Mibelli175800C0949506OMIM1249141607622
HP:0008069HP:0008069Neoplasm of the skin0PMVK CL E G H10654175800Porokeratosis of Mibelli175800C0949506OMIM1289141607622
HP:0008069HP:0008069Neoplasm of the skin0RMRP CL E G H6023250250Metaphyseal chondrodysplasia, McKusick type250250C0220748OMIM160910031157660
HP:0008069HP:0008069Neoplasm of the skin0RMRP CL E G H6023250250Metaphyseal chondrodysplasia, McKusick type250250C0220748OMIM149810031157660
HP:0008069HP:0008069Neoplasm of the skin0TNFRSF1B CL E G H71332584ORPHA15611917191191
HP:0008069HP:0008069Neoplasm of the skin0TNFRSF1B CL E G H71332584ORPHA15211917191191
HP:0008069HP:0008069Neoplasm of the skin0TNFRSF1B CL E G H71333162Lactate dehydrogenase deficiency type CORPHA15211917191191
HP:0008069HP:0008069Neoplasm of the skin0TNFRSF1B CL E G H71333162Lactate dehydrogenase deficiency type CORPHA15611917191191
HP:0008069HP:0008069Neoplasm of the skin0TP53 CL E G H7157524Acute megakaryoblastic leukemiaC0023462ORPHA1228011998191170
HP:0008069HP:0008069Neoplasm of the skin0TP53 CL E G H7157524Acute megakaryoblastic leukemiaC0023462ORPHA1246411998191170
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0025432Acanthoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0009593Peripheral Schwannoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0006769Myxoid subcutaneous tumors1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0002671Basal cell carcinoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0030447Merkel cell skin cancer1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0031018Eccrine syringofibroadenoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0002860Squamous cell carcinoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0007620Cutaneous leiomyoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0007541Frontal cutaneous lipoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0200151Cutaneous mastocytosis1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0012056Cutaneous melanoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0031525Keratoacanthoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0001031Subcutaneous lipoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0025432Acanthoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0009593Peripheral Schwannoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0006769Myxoid subcutaneous tumors1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0002671Basal cell carcinoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0030447Merkel cell skin cancer1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0031018Eccrine syringofibroadenoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0002860Squamous cell carcinoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0007620Cutaneous leiomyoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0007541Frontal cutaneous lipoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0200151Cutaneous mastocytosis1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0012056Cutaneous melanoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0031525Keratoacanthoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0001031Subcutaneous lipoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0031549Lymphocytoma cutis1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0032225Perifollicular fibroma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0007606Multiple cutaneous malignancies1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0025127Actinic keratosis1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0012740Papilloma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0030428Cutaneous myxoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0031287Seborrheic keratosis1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0001067Neurofibromas1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0006773Cutaneous angiolipomas1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0012842Skin appendage neoplasm1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0030436Fibrofolliculoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0100726Kaposi's sarcoma1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0012035Steatocystoma multiplex1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0009720Adenoma sebaceum1CD28 CL E G H9402584ORPHA1301653186760
HP:0008069HP:0032225Perifollicular fibroma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0007606Multiple cutaneous malignancies1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0025127Actinic keratosis1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0012740Papilloma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0030428Cutaneous myxoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0031287Seborrheic keratosis1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0001067Neurofibromas1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0006773Cutaneous angiolipomas1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0012842Skin appendage neoplasm1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0030436Fibrofolliculoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0100726Kaposi's sarcoma1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0012035Steatocystoma multiplex1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0009720Adenoma sebaceum1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0031549Lymphocytoma cutis1CD28 CL E G H9402584ORPHA1281653186760
HP:0008069HP:0025432Acanthoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0009593Peripheral Schwannoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0006769Myxoid subcutaneous tumors1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0002671Basal cell carcinoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0030447Merkel cell skin cancer1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0031018Eccrine syringofibroadenoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0002860Squamous cell carcinoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0007620Cutaneous leiomyoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0007541Frontal cutaneous lipoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0200151Cutaneous mastocytosis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0012056Cutaneous melanoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0031525Keratoacanthoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0001031Subcutaneous lipoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0009593Peripheral Schwannoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0006769Myxoid subcutaneous tumors1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0002671Basal cell carcinoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0030447Merkel cell skin cancer1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0031018Eccrine syringofibroadenoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0002860Squamous cell carcinoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0007620Cutaneous leiomyoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0007541Frontal cutaneous lipoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0200151Cutaneous mastocytosis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0012056Cutaneous melanoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0031525Keratoacanthoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0001031Subcutaneous lipoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0025432Acanthoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0007606Multiple cutaneous malignancies1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0025127Actinic keratosis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0012740Papilloma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0030428Cutaneous myxoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0031287Seborrheic keratosis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0001067Neurofibromas1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0006773Cutaneous angiolipomas1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0012842Skin appendage neoplasm1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0030436Fibrofolliculoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0100726Kaposi's sarcoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0012035Steatocystoma multiplex1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0009720Adenoma sebaceum1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0031549Lymphocytoma cutis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0032225Perifollicular fibroma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1301653186760
HP:0008069HP:0025127Actinic keratosis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0012740Papilloma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0030428Cutaneous myxoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0031287Seborrheic keratosis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0001067Neurofibromas1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0006773Cutaneous angiolipomas1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0012842Skin appendage neoplasm1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0030436Fibrofolliculoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0100726Kaposi's sarcoma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0012035Steatocystoma multiplex1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0009720Adenoma sebaceum1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0031549Lymphocytoma cutis1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0032225Perifollicular fibroma1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0007606Multiple cutaneous malignancies1CD28 CL E G H9403162Lactate dehydrogenase deficiency type CORPHA1281653186760
HP:0008069HP:0200151Cutaneous mastocytosis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0012056Cutaneous melanoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0031525Keratoacanthoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0001031Subcutaneous lipoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0025432Acanthoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0009593Peripheral Schwannoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0006769Myxoid subcutaneous tumors1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0002671Basal cell carcinoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0030447Merkel cell skin cancer1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0031018Eccrine syringofibroadenoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0002860Squamous cell carcinoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0007620Cutaneous leiomyoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0007541Frontal cutaneous lipoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0031525Keratoacanthoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0001031Subcutaneous lipoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0025432Acanthoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0009593Peripheral Schwannoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0006769Myxoid subcutaneous tumors1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0002671Basal cell carcinoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0030447Merkel cell skin cancer1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0031018Eccrine syringofibroadenoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0002860Squamous cell carcinoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0007620Cutaneous leiomyoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0007541Frontal cutaneous lipoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0200151Cutaneous mastocytosis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0012056Cutaneous melanoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0009720Adenoma sebaceum1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0031549Lymphocytoma cutis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0032225Perifollicular fibroma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0007606Multiple cutaneous malignancies1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0025127Actinic keratosis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0012740Papilloma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0030428Cutaneous myxoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0031287Seborrheic keratosis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0001067Neurofibromas1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0006773Cutaneous angiolipomas1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0012842Skin appendage neoplasm1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0030436Fibrofolliculoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0100726Kaposi's sarcoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0012035Steatocystoma multiplex1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA110621787600160
HP:0008069HP:0009720Adenoma sebaceum1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0031549Lymphocytoma cutis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0032225Perifollicular fibroma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0007606Multiple cutaneous malignancies1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0025127Actinic keratosis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0012740Papilloma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0030428Cutaneous myxoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0031287Seborrheic keratosis1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0001067Neurofibromas1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0006773Cutaneous angiolipomas1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0012842Skin appendage neoplasm1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0030436Fibrofolliculoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0100726Kaposi's sarcoma1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0012035Steatocystoma multiplex1CDKN2A CL E G H1029524Acute megakaryoblastic leukemiaC0023462ORPHA19711787600160
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0100726Kaposi's sarcoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0012035Steatocystoma multiplex1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0009720Adenoma sebaceum1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0031549Lymphocytoma cutis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0032225Perifollicular fibroma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0007606Multiple cutaneous malignancies1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0025127Actinic keratosis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0012740Papilloma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0030428Cutaneous myxoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0031287Seborrheic keratosis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0001067Neurofibromas1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0006773Cutaneous angiolipomas1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0012842Skin appendage neoplasm1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0030436Fibrofolliculoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0100726Kaposi's sarcoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0012035Steatocystoma multiplex1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0009720Adenoma sebaceum1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0031549Lymphocytoma cutis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0032225Perifollicular fibroma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0007606Multiple cutaneous malignancies1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0025127Actinic keratosis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0012740Papilloma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0030428Cutaneous myxoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0031287Seborrheic keratosis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0001067Neurofibromas1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0006773Cutaneous angiolipomas1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0012842Skin appendage neoplasm1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0030436Fibrofolliculoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0007620Cutaneous leiomyoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0007541Frontal cutaneous lipoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0200151Cutaneous mastocytosis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0012056Cutaneous melanoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0031525Keratoacanthoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0001031Subcutaneous lipoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0025432Acanthoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0009593Peripheral Schwannoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0006769Myxoid subcutaneous tumors1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0002671Basal cell carcinoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0030447Merkel cell skin cancer1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0031018Eccrine syringofibroadenoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0002860Squamous cell carcinoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1285116627604373
HP:0008069HP:0007541Frontal cutaneous lipoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0200151Cutaneous mastocytosis1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0012056Cutaneous melanoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0031525Keratoacanthoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0001031Subcutaneous lipoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0025432Acanthoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0009593Peripheral Schwannoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0006769Myxoid subcutaneous tumors1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0002671Basal cell carcinoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0030447Merkel cell skin cancer1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0031018Eccrine syringofibroadenoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0002860Squamous cell carcinoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0007620Cutaneous leiomyoma1CHEK2 CL E G H11200524Acute megakaryoblastic leukemiaC0023462ORPHA1259416627604373
HP:0008069HP:0032225Perifollicular fibroma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0007606Multiple cutaneous malignancies1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0025127Actinic keratosis1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0012740Papilloma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0030428Cutaneous myxoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0031287Seborrheic keratosis1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0001067Neurofibromas1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0006773Cutaneous angiolipomas1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0012842Skin appendage neoplasm1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0030436Fibrofolliculoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0006755Cutaneous leiomyosarcoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0100726Kaposi's sarcoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0012035Steatocystoma multiplex1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0009720Adenoma sebaceum1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0031549Lymphocytoma cutis1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0007437Multiple cutaneous leiomyomas1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0025432Acanthoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0009593Peripheral Schwannoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0006769Myxoid subcutaneous tumors1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0002671Basal cell carcinoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0030447Merkel cell skin cancer1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0031018Eccrine syringofibroadenoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0002860Squamous cell carcinoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0007620Cutaneous leiomyoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0007541Frontal cutaneous lipoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0200151Cutaneous mastocytosis1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0012056Cutaneous melanoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0031525Keratoacanthoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0001031Subcutaneous lipoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0025432Acanthoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0009593Peripheral Schwannoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0006769Myxoid subcutaneous tumors1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0002671Basal cell carcinoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0030447Merkel cell skin cancer1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0031018Eccrine syringofibroadenoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0002860Squamous cell carcinoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0007620Cutaneous leiomyoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0007541Frontal cutaneous lipoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0200151Cutaneous mastocytosis1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0012056Cutaneous melanoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0031525Keratoacanthoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0001031Subcutaneous lipoma1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0007437Multiple cutaneous leiomyomas1COL1A1 CL E G H127731112ORPHA113972197120150
HP:0008069HP:0032225Perifollicular fibroma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0007606Multiple cutaneous malignancies1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0025127Actinic keratosis1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0012740Papilloma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0030428Cutaneous myxoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0031287Seborrheic keratosis1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0001067Neurofibromas1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0006773Cutaneous angiolipomas1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0012842Skin appendage neoplasm1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0030436Fibrofolliculoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0006755Cutaneous leiomyosarcoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0100726Kaposi's sarcoma1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0012035Steatocystoma multiplex1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0009720Adenoma sebaceum1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0031549Lymphocytoma cutis1COL1A1 CL E G H127731112ORPHA116552197120150
HP:0008069HP:0031525Keratoacanthoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0001031Subcutaneous lipoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0025432Acanthoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0009593Peripheral Schwannoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0006769Myxoid subcutaneous tumors1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0002671Basal cell carcinoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0031018Eccrine syringofibroadenoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0002860Squamous cell carcinoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0007620Cutaneous leiomyoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0007541Frontal cutaneous lipoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0012056Cutaneous melanoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0009720Adenoma sebaceum1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0012842Skin appendage neoplasm1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0100726Kaposi's sarcoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0012035Steatocystoma multiplex1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0031549Lymphocytoma cutis1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0032225Perifollicular fibroma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0007606Multiple cutaneous malignancies1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0025127Actinic keratosis1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0012740Papilloma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0030428Cutaneous myxoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0031287Seborrheic keratosis1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0001067Neurofibromas1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0006773Cutaneous angiolipomas1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0030436Fibrofolliculoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0009720Adenoma sebaceum1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0012842Skin appendage neoplasm1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0031549Lymphocytoma cutis1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0032225Perifollicular fibroma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0007606Multiple cutaneous malignancies1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0025127Actinic keratosis1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0012740Papilloma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0030428Cutaneous myxoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0031287Seborrheic keratosis1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0001067Neurofibromas1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0006773Cutaneous angiolipomas1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0030436Fibrofolliculoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0100726Kaposi's sarcoma1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0012035Steatocystoma multiplex1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0200151Cutaneous mastocytosis1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0030447Merkel cell skin cancer1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0012056Cutaneous melanoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0031525Keratoacanthoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0001031Subcutaneous lipoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0025432Acanthoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0009593Peripheral Schwannoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0006769Myxoid subcutaneous tumors1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0002671Basal cell carcinoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0031018Eccrine syringofibroadenoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0002860Squamous cell carcinoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0007620Cutaneous leiomyoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0007541Frontal cutaneous lipoma1CTLA4 CL E G H14932584ORPHA11722505123890
HP:0008069HP:0030447Merkel cell skin cancer1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0200151Cutaneous mastocytosis1CTLA4 CL E G H14932584ORPHA11462505123890
HP:0008069HP:0031549Lymphocytoma cutis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0032225Perifollicular fibroma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0007606Multiple cutaneous malignancies1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0025127Actinic keratosis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0012740Papilloma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0030428Cutaneous myxoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0031287Seborrheic keratosis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0001067Neurofibromas1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0006773Cutaneous angiolipomas1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0012842Skin appendage neoplasm1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0030436Fibrofolliculoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0100726Kaposi's sarcoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0012035Steatocystoma multiplex1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0009720Adenoma sebaceum1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0032225Perifollicular fibroma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0007606Multiple cutaneous malignancies1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0025127Actinic keratosis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0012740Papilloma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0030428Cutaneous myxoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0031287Seborrheic keratosis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0001067Neurofibromas1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0006773Cutaneous angiolipomas1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0012842Skin appendage neoplasm1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0030436Fibrofolliculoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0100726Kaposi's sarcoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0012035Steatocystoma multiplex1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0009720Adenoma sebaceum1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0031549Lymphocytoma cutis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0025432Acanthoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0009593Peripheral Schwannoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0006769Myxoid subcutaneous tumors1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0002671Basal cell carcinoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0030447Merkel cell skin cancer1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0031018Eccrine syringofibroadenoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0002860Squamous cell carcinoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0007620Cutaneous leiomyoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0007541Frontal cutaneous lipoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0200151Cutaneous mastocytosis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0012056Cutaneous melanoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0031525Keratoacanthoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0001031Subcutaneous lipoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11722505123890
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0025432Acanthoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0009593Peripheral Schwannoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0006769Myxoid subcutaneous tumors1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0002671Basal cell carcinoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0030447Merkel cell skin cancer1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0031018Eccrine syringofibroadenoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0002860Squamous cell carcinoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0007620Cutaneous leiomyoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0007541Frontal cutaneous lipoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0200151Cutaneous mastocytosis1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0012056Cutaneous melanoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0031525Keratoacanthoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0001031Subcutaneous lipoma1CTLA4 CL E G H14933162Lactate dehydrogenase deficiency type CORPHA11462505123890
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0025432Acanthoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0009593Peripheral Schwannoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0006769Myxoid subcutaneous tumors1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0002671Basal cell carcinoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0030447Merkel cell skin cancer1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0031018Eccrine syringofibroadenoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0002860Squamous cell carcinoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0007620Cutaneous leiomyoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0007541Frontal cutaneous lipoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0200151Cutaneous mastocytosis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0012056Cutaneous melanoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0031525Keratoacanthoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0001031Subcutaneous lipoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0025432Acanthoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0009593Peripheral Schwannoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0006769Myxoid subcutaneous tumors1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0002671Basal cell carcinoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0030447Merkel cell skin cancer1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0031018Eccrine syringofibroadenoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0002860Squamous cell carcinoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0007620Cutaneous leiomyoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0007541Frontal cutaneous lipoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0200151Cutaneous mastocytosis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0012056Cutaneous melanoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0031525Keratoacanthoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0001031Subcutaneous lipoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0032225Perifollicular fibroma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0007606Multiple cutaneous malignancies1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0025127Actinic keratosis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0012740Papilloma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0030428Cutaneous myxoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0031287Seborrheic keratosis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0001067Neurofibromas1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0006773Cutaneous angiolipomas1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0012842Skin appendage neoplasm1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0030436Fibrofolliculoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0100726Kaposi's sarcoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0012035Steatocystoma multiplex1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0009720Adenoma sebaceum1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0031549Lymphocytoma cutis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM13642514116806
HP:0008069HP:0032225Perifollicular fibroma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0007606Multiple cutaneous malignancies1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0025127Actinic keratosis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0012740Papilloma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0030428Cutaneous myxoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0031287Seborrheic keratosis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0001067Neurofibromas1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0006773Cutaneous angiolipomas1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0012842Skin appendage neoplasm1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0030436Fibrofolliculoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0100726Kaposi's sarcoma1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0012035Steatocystoma multiplex1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0009720Adenoma sebaceum1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0031549Lymphocytoma cutis1CTNNB1 CL E G H1499132600Pilomatrixoma132600C0206711OMIM12692514116806
HP:0008069HP:0007541Frontal cutaneous lipoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0200151Cutaneous mastocytosis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0012056Cutaneous melanoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0031525Keratoacanthoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0001031Subcutaneous lipoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0025432Acanthoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0009593Peripheral Schwannoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0006769Myxoid subcutaneous tumors1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0002671Basal cell carcinoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0030447Merkel cell skin cancer1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0031018Eccrine syringofibroadenoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0002860Squamous cell carcinoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0007620Cutaneous leiomyoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0007541Frontal cutaneous lipoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0200151Cutaneous mastocytosis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0012056Cutaneous melanoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0031525Keratoacanthoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0001031Subcutaneous lipoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0007437Multiple cutaneous leiomyomas1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0025432Acanthoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0009593Peripheral Schwannoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0006769Myxoid subcutaneous tumors1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0002671Basal cell carcinoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0030447Merkel cell skin cancer1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0031018Eccrine syringofibroadenoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0002860Squamous cell carcinoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0007620Cutaneous leiomyoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0100726Kaposi's sarcoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0012035Steatocystoma multiplex1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0009720Adenoma sebaceum1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0031549Lymphocytoma cutis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0032225Perifollicular fibroma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0007606Multiple cutaneous malignancies1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0025127Actinic keratosis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0012740Papilloma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0030428Cutaneous myxoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0031287Seborrheic keratosis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0001067Neurofibromas1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0006773Cutaneous angiolipomas1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0012842Skin appendage neoplasm1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0030436Fibrofolliculoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12462584605018
HP:0008069HP:0006755Cutaneous leiomyosarcoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0100726Kaposi's sarcoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0012035Steatocystoma multiplex1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0009720Adenoma sebaceum1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0031549Lymphocytoma cutis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0032225Perifollicular fibroma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0007606Multiple cutaneous malignancies1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0025127Actinic keratosis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0012740Papilloma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0030428Cutaneous myxoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0031287Seborrheic keratosis1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0001067Neurofibromas1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0006773Cutaneous angiolipomas1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0012842Skin appendage neoplasm1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0030436Fibrofolliculoma1CYLD CL E G H1540132700Cylindromatosis, familial132700C1851526OMIM12442584605018
HP:0008069HP:0100726Kaposi's sarcoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0012035Steatocystoma multiplex1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0009720Adenoma sebaceum1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0031549Lymphocytoma cutis1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0032225Perifollicular fibroma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0007606Multiple cutaneous malignancies1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0025127Actinic keratosis1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0012740Papilloma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0030428Cutaneous myxoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0031287Seborrheic keratosis1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0001067Neurofibromas1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0006773Cutaneous angiolipomas1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0012842Skin appendage neoplasm1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0030436Fibrofolliculoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0006755Cutaneous leiomyosarcoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0200151Cutaneous mastocytosis1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0012056Cutaneous melanoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0031525Keratoacanthoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0001031Subcutaneous lipoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0007437Multiple cutaneous leiomyomas1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0025432Acanthoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0009593Peripheral Schwannoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0006769Myxoid subcutaneous tumors1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0002671Basal cell carcinoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0030447Merkel cell skin cancer1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0031018Eccrine syringofibroadenoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0002860Squamous cell carcinoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0007620Cutaneous leiomyoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0007541Frontal cutaneous lipoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0200151Cutaneous mastocytosis1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0012056Cutaneous melanoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0031525Keratoacanthoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0001031Subcutaneous lipoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0007437Multiple cutaneous leiomyomas1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0025432Acanthoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0009593Peripheral Schwannoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0006769Myxoid subcutaneous tumors1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0002671Basal cell carcinoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0030447Merkel cell skin cancer1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0031018Eccrine syringofibroadenoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0002860Squamous cell carcinoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0007620Cutaneous leiomyoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0007541Frontal cutaneous lipoma1LMNA CL E G H400079474ORPHA113476636150330
HP:0008069HP:0006755Cutaneous leiomyosarcoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0100726Kaposi's sarcoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0012035Steatocystoma multiplex1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0009720Adenoma sebaceum1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0031549Lymphocytoma cutis1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0032225Perifollicular fibroma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0007606Multiple cutaneous malignancies1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0025127Actinic keratosis1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0012740Papilloma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0030428Cutaneous myxoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0031287Seborrheic keratosis1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0001067Neurofibromas1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0006773Cutaneous angiolipomas1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0012842Skin appendage neoplasm1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0030436Fibrofolliculoma1LMNA CL E G H400079474ORPHA114866636150330
HP:0008069HP:0030447Merkel cell skin cancer1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0031018Eccrine syringofibroadenoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0002860Squamous cell carcinoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0007620Cutaneous leiomyoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0007541Frontal cutaneous lipoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0200151Cutaneous mastocytosis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0012056Cutaneous melanoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0031525Keratoacanthoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0001031Subcutaneous lipoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0007437Multiple cutaneous leiomyomas1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0025432Acanthoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0009593Peripheral Schwannoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0006769Myxoid subcutaneous tumors1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0002671Basal cell carcinoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0031018Eccrine syringofibroadenoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0002860Squamous cell carcinoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0007620Cutaneous leiomyoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0007541Frontal cutaneous lipoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0200151Cutaneous mastocytosis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0012056Cutaneous melanoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0031525Keratoacanthoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0001031Subcutaneous lipoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0007437Multiple cutaneous leiomyomas1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0025432Acanthoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0009593Peripheral Schwannoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0006769Myxoid subcutaneous tumors1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0002671Basal cell carcinoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0030447Merkel cell skin cancer1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0001067Neurofibromas1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0006773Cutaneous angiolipomas1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0012842Skin appendage neoplasm1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0030436Fibrofolliculoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0006755Cutaneous leiomyosarcoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0100726Kaposi's sarcoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0012035Steatocystoma multiplex1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0009720Adenoma sebaceum1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0031549Lymphocytoma cutis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0032225Perifollicular fibroma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0007606Multiple cutaneous malignancies1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0025127Actinic keratosis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0012740Papilloma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0030428Cutaneous myxoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0031287Seborrheic keratosis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1756973164785
HP:0008069HP:0006773Cutaneous angiolipomas1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0012842Skin appendage neoplasm1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0030436Fibrofolliculoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0006755Cutaneous leiomyosarcoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0100726Kaposi's sarcoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0012035Steatocystoma multiplex1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0009720Adenoma sebaceum1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0031549Lymphocytoma cutis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0032225Perifollicular fibroma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0007606Multiple cutaneous malignancies1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0025127Actinic keratosis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0012740Papilloma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0030428Cutaneous myxoma1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0031287Seborrheic keratosis1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0001067Neurofibromas1MDM2 CL E G H4193524Acute megakaryoblastic leukemiaC0023462ORPHA1496973164785
HP:0008069HP:0009720Adenoma sebaceum1MUTYH CL E G H4595132600Pilomatrixoma132600C0206711OMIM119097527604933
HP:0008069HP:0031549Lymphocytoma cutis1MUTYH CL E G H4595132600